A targeted approach to age related disease: nanomedicines and the liver sinusoidal endothelium

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cells that line the liver blood vessels undergo predictable and distinct changes with age that increase the risk of developing diseases of older age like Diabetes and Cardiovascular Disease. We can now selectively target the changes in the liver cells with nanomedicines to prevent and treat these changes. The implications of this study are vast – a new therapy for the prevention and treatment of age-related cardiovascular disease and diabetes.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $560,241.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nanomedicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ageing | disease mechanisms | drug delivery systems | liver microcirculation | nanotechnology